Emergence client, Chinova Bioworks, receives GRAS designation in the U.S.

October 22, 2018

Emergence client, Fredericton, New Brunswick-based Chinova Bioworks, has received its designation as GRAS (Generally Recognized as Safe) by an independent expert panel.

chinova_logo_1-2-7-printThis designation is based on the U.S. Food and Drug Administration (FDA) requirements.

The GRAS determination applies exclusively to Chinova Bioworks’ mushroom chitosan preservative, and for specific uses that Chinova has designated.


Chinova Bioworks CEO, Natasha Dhayagude

“Having our Chiber™ mushroom chitosan ingredient recognized as GRAS allows us to commercialize our natural solution in the U.S. market for the first time,” Chinova CEO Natasha Dhayagude told us.

According to Dhayagude, “[GRAS status] demonstrates Chinova’s commitment to the highest standards of quality and safety of our ingredient.”

“This is an important milestone for us and an exciting development for our customers who are eager to replace artificial preservatives and make their foods and beverages healthy and clean label.”

Chinova’s Chiber™ is an antimicrobial food and beverage preservative made from a fiber extracted from mushrooms, called chitosan. It has the advantages of broad-spectrum antimicrobial effectiveness while being a healthy natural fiber.

About Chinova

Chinova Bioworks is a Canadian company that addresses the growing consumer demand for healthy, natural, clean-label ingredients, while providing producers with an effective solution that ensures food safety, shelf life, and the overall quality of the product. The company has developed an innovative preservative ingredient based on a fiber extracted from mushrooms called chitosan. This ingredient, Chiber™, offers broad-spectrum protection against all types of microorganisms (bacteria, yeast, and mold), is easy to use, and has no organoleptic impact, all at a competitive price point.

See also: Emergence client, Chinova Bioworks, raises US$2 million seed financing round and Emergence client, Chinova Bioworks, profiled by Rabobank